TGFB1 and intrahepatic cholangiocarcinoma: Zhang et al. (2022) confirmed that TGF-β/Smad signaling pathway activation can induce epithelial–mesenchymal transition, causing abnormal ICC distribution and dysfunction in the diseased colon, ultimately promoting the occurrence and development of slow transit constipation.